Improving outcomes for patients with cardiogenic shock in Lower Silesia
Coordinated Treatment of Cardiogenic Shock Patients in Lower Silesia, Poland
This study is trying to improve treatment for people in Lower Silesia who are experiencing cardiogenic shock by using a new system to decide who needs to be transferred to a specialized hospital for better care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Wroclaw Medical University Academic / other |
| Locations | 1 site (Wroclaw) |
| Trial ID | NCT05465200 on ClinicalTrials.gov |
What this trial studies
The Lower Silesia Cardiogenic Shock Initiative aims to enhance the treatment outcomes for patients experiencing cardiogenic shock in the Lower Silesia region of Poland. This project utilizes a Hub&Spoke model, with Wroclaw University Hospital serving as the central hub and eleven cardiology departments as spokes. A unified protocol has been established to determine which patients should be transferred to the hub for advanced treatment options, including mechanical circulatory support and heart transplants. The hub is staffed with a dedicated Shock Team available 24/7 to manage patient care and treatment decisions.
Who should consider this trial
Good fit: Ideal candidates for this initiative are adults aged 18 to 60 who meet the criteria for cardiogenic shock and have experienced shock for less than 24 hours.
Not a fit: Patients with irreversible multiorgan failure, end-stage chronic diseases, or a history of cardiac arrest with anoxemic brain injury may not benefit from this initiative.
Why it matters
Potential benefit: If successful, this initiative could significantly improve survival rates and quality of life for patients suffering from cardiogenic shock.
How similar studies have performed: Other studies utilizing Hub&Spoke models for critical care have shown promising results, indicating that this approach may be effective in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Fulfilled definition of cardiogenic shock 2. Age 18 - 60 years 3. Shock duration below 24 hours Exclusion Criteria: 1. History of cardiac arrest with anoxemic brain injury 2. Irreversible multiorgan failure 3. End stage of chronic diseases other than heart failure 4. Neoplastic disease 5. Lack of vascular access
Where this trial is running
Wroclaw
- Institute of Heart Disease of Wroclaw Medical University — Wroclaw, Poland (Recruiting)
Study contacts
- Study coordinator: Wiktor Kuliczkowski
- Email: wiktor.kuliczkowski@umed.wroc.pl
- Phone: +48717331112
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.